摘要
为了研究稻米中Cr的生物可给性,并对由稻米途径摄入Cr所引起的人体健康风险进行评估,从市场收集了16种稻米样品,采用in vitro方法(PBET和SHIME联用)研究了这些稻米样品中Cr在胃、小肠和结肠3个阶段的生物可给性及其对人体的健康风险。结果表明,16个稻米样品中Cr的含量均未超过国家食品卫生标准(GB 2762—2017)中规定的Cr的限量标准(1.0 mg·kg^(-1))。稻米中Cr在胃、小肠和结肠3个阶段的生物可给性分别为34.3%~66.1%、46.4%~89.1%和64.4%~94.5%,平均值为52.5%、75.1%和83.0%,小肠阶段Cr的生物可给性是胃阶段的1.4倍,结肠阶段Cr的生物可给性是小肠阶段的1.1倍,可见肠道微生物可以促进稻米中Cr的溶出释放。在人体健康风险评价中,成人和儿童的健康风险指数危害商(HQ)均<1.0,说明市场所售稻米中Cr对人体健康风险较小。
To investigate the bioaccessibility of chromium(Cr)in rice and to evaluate the human health risk of Cr due to rice intake,16 rice samples were collected from the market.The in vitro method,including PBET method(physiologically based extraction test)and SHIME model(simulator of human intestinal microbial ecosystem),were used to study the Cr bioaccessibility in the gastric,small intestinal and colon phases respectively.Subsequently the human health risk of Cr was assessed.The content of Cr in the 16 rice samples did not exceed the limit standard of Cr stipulated in the National Food Hygiene Standard(GB 2762—2017)(1.0 mg·kg^(-1)).The bioaccessibilities of Cr in the three phases of the gastric,small intestinal and colon were 34.3%~66.1%,46.4%~89.1%,and 64.4%~94.5%,respectively,with the average values of 52.5%,75.1%and 83.0%,respectively.The bioaccessibility of Cr in the small intestinal phase was 1.4 times higher than that in the gastric phase,and the bioaccessibility of Cr in the colon phase was 1.1 times higher than that in the small intestinal phase.Human gut microbiota can promote the rice Cr release.In human health risk assessment,the hazard quotient of adults and children were less than 1.0,indicating that Cr in sold rice may induce less risks to human health.
作者
耿紫琪
王鹏飞
付雅祺
刘文菊
崔岩山
Geng Ziqi;Wang Pengfei;Fu Yaqi;Liu Wenju;Cui Yanshan(University of Chinese Academy of Sciences,Beijing 100049,China;Agricultural University of Hebei,Baoding 071000,China)
出处
《生态毒理学报》
CAS
CSCD
北大核心
2020年第6期205-211,共7页
Asian Journal of Ecotoxicology
基金
中国科学院大学生创新实践训练计划基金
国家自然科学基金资助项目(41877501)。